WGSGeneDx Holdings Corp.
$57.54-51% 1Y
$57.54
$34.5152 weeks$167.51
Is the price fair?
What WGS's price assumes
GeneDx Holdings Corp. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.78× revenue.
3.78
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 7.03
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 3.70
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 7.03
- EV / EBIToperating margin −20%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 3.70
- Market capitalisation29.8 million shares, counted Jul 27, 2026
- $1.72B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Diagnostics & Research
Ranks #9 of 21 by RyuScore